Effect of Lactobacillus Reuteri DSM 17938 to Prevent Antibiotic-associated Diarrhea in Children: Prospective, Multi-center, Randomize, Parallel Group Placebo Controlled Clinical Trial
Phase of Trial: Phase IV
Latest Information Update: 01 Aug 2017
At a glance
- Drugs Lactobacillus reuteri (Primary) ; Amoxicillin/clavulanic acid
- Indications Diarrhoea
- Focus Therapeutic Use
- Acronyms PEARL
- 25 Jul 2017 Planned End Date changed from 1 Jun 2018 to 1 Sep 2018.
- 25 Jul 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Jul 2018.
- 25 Jul 2017 Status changed from not yet recruiting to recruiting.